Security key
48115J109
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 11,773,873
- Total reported value
- $55,217,591
- Share change
- +243,351
- Reported price per share
- $4.69
- Number of holders
- 70
- Value change
- -$1,855,627
- Number of buys
- 39
- Number of sells
- 34
- Shares outstanding
- 21,352,124
Holder snapshot
6 facts
Security identity
1 fact
Report period
Q1 2026
Institutions
70
Top holders
10
DERM full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q4 2025
Journey Medical Corp SEC filings
Journey Medical Corp company facts
Broader feeds
Reporting periods
Holder history for CUSIP 48115J109
Recent filing periods:
Ownership snapshot
Top reported holders of DERM - Journey Medical Corp - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Lead holder
WASATCH ADVISORS LP
13D/G signal
WASATCH ADVISORS LP
Evidence rows
15
Latest as of
31 Mar 2026
13D/G
13F
3/4/5
Lead comparable stake: 10%
13D/G row: WASATCH ADVISORS LP
Showing 1-6 of 15 holder rows.
Rank 1 holder
WASATCH ADVISORS LP
13D/G
13F
- Ownership
- 10%
- Position
- $16.55M
Rank 2 holder
TANG CAPITAL MANAGEMENT LLC
13F
13D/G
- Ownership
- 8%
- Position
- $14.3M
Rank 3 holder
VANGUARD CAPITAL MANAGEMENT LLC
13D/G
- Ownership
- 5.6%
- Position
- $5.66M
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| WASATCH ADVISORS LP |
13D/G
13F
Company
|
10%
|
$16,554,951
2,133,370 shares
|
+$7,614,973 | 31 Mar 2026 |
| TANG CAPITAL MANAGEMENT LLC |
13F
13D/G
Company
|
8%
from 13D/G
|
$14,298,935
1,854,596 shares
|
— | 31 Dec 2025 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13D/G
Vanguard Capital Management
|
5.6%
|
$5,657,993
1,206,395 shares
|
$0 | 31 Mar 2026 |
| Lindsay A. Rosenwald MD |
3/4/5
Director
|
1.8%
|
$2,682,302
387,616 shares
|
— | 05 Aug 2025 |
| Justin Adam Smith |
3/4/5
Director
|
0.8%
|
$1,187,596
171,618 shares
|
— | 05 Aug 2025 |
| Miranda Jayne Toledano |
3/4/5
Director
|
0.51%
|
$751,636
108,618 shares
|
— | 05 Aug 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
70
Shares
11,773,873
Rows available
70
| Investor | Option | Weight % | Change % | Reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
76
Q1 2026 holders
70
Holder diff
-6
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 value | Q1 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend